Mariposa Therapeutics

Mariposa develops solutions for patients with epidermolysis bullosa simplex (EBS). Its first solution is derived from the unique chemistry and biological activity of ajoene, a metabolite of crushed garlic. Grounded on its unique expertise in ajoene chemistry and its biological activities, Mariposa has identified synthetic analogues of this small molecule that activate surrogate keratin expression, thereby functionally compensating for the genetic defect in EB simplex patients.
Social Link - Linkedin: http://www. linkedin.com/company /mariposa-therapeutics
Employee Count: 5
Keywords: biotechnology research